General demographic feature of healthy subjects
A total of 30 healthy subjects in the First Affiliated Hospital of Guangzhou Medical University, 12 males and 18 females, aged from 23 to 65 years, were enrolled in this study. This study found no evidence of a gender bias regarding the CT values of GAPDH in OP swab specimens (27.3 ± 1.5 in males vs 27.0 ± 2.2 in females, P = 0.669). In addition, there were no significant associations between ages and the CT values of GAPDH (P = 0.408).
Associations between sampling forces and the qualities of OP swabs
The sampling force, which was the non-normally distributed variable (Kolmogorov-Smirnov test, P < 0.05), was presented as median and IQRs. The maximum of sampling force was also documented in the current study. In addition, the positive association between the median and maximum sampling force was identified (r = 0.72, P < 0.001) (shown in Fig. 2). However, no significant relativities between the median sampling forces and qualities of OP swab (the CT values of GAPDH) were found in this study (r=-0.079, P = 0.547) (shown in Fig. 3).
Effect of different sampling medical doctors on the quality of OP swabs
The median and maximum sampling forces were remarkedly differed from different sampling doctors (P < 0.001) (Table 1). However, the mRNA expression of GAPDH of OP swabs specimens that were taken by two different doctors showed no statistical difference, indicating the qualities of OP swabs were irrelevant to the sampling forces. Regarding the side effects of unsuitable sampling force, group B showed more obvious adverse effects than group A (7/30 vs 0/30, P = 0.011) (Table 1). In fact, 7 out of the 30 participants (23.3%) in group B had side effects, with nausea (71.0%) being the most common, followed by pain (28.6%) (Table 2).
Table 1
The quality and adverse effect of OP swab specimen obtained by two different doctors
|
Group A
N = 30
|
Group B
N = 30
|
P
|
Median force (g)
|
52.7 ± 24.4
|
132.6 ± 35.7
|
<0.001
|
Maximum force (g)
|
11.4 ± 4.7
|
37.7 ± 11.2
|
<0.001
|
CT values of GAPDH
|
27.3 ± 1.9
|
27.0 ± 2.0
|
0.578
|
Adverse effect
|
0%(0/30)
|
23.3(7/30)
|
0.011
|
Table 2
Adverse effect in two groups
Adverse effect
|
Group A
|
Group B
|
Nausea
|
0
|
71%(5/7)
|
Pain
|
0
|
28.6%(2/7)
|
Others
|
0
|
57%(4/7)
|
Congestion of throat
|
0
|
0(0/7)
|
Damage of throat
|
0
|
0(0/7)
|
Effect of different ranges of sampling force on the result of OP swabs
Three groups(low level: 0–20 g, middle level: 20–40 g, high level: > 40 g)of sampling force were classified in this study. The mRNA expressions of GAPDH presented no significant difference among three groups (P = 0.873) (shown in Fig. 4). However, it was observed that the incidence of side effects was significantly increased in the middle and high level groups, compared to the low level group (P < 0.002) (Table 3).
Table 3
Comparation of adverse effect in different sampling force groups
Groups
|
The proportion of adverse effect(%)
|
Low level group (0-20g)
|
0 (0/30)
|
Middle level group (20-40g)
|
15 (3/20)
|
High level group (>40g)
|
40 (4/10)
|